SCHEMBL6403463

SCHEMBL6403463

COc1ccc(-n2c(SCc3ccccc3)nnc2-c2ccncc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.73
CYP2C9 P11712 3/20 0.73
TNKS2 Q9H2K2 5/20 0.69
TNKS O95271 3/20 0.69
SMN1; SMN2 Q16637 4/20 0.68
HPGD P15428 2/20 0.68
GAA P10253 1/20 0.68
MAPK1 P28482 1/20 0.68
TP53 P04637 2/20 0.66
TSHR P16473 3/20 0.66
NPC1 O15118 1/20 0.66
ALDH1A1 P00352 1/20 0.66
RAB9A P51151 1/20 0.66
MAPT P10636 2/20 0.64
THRB P10828 1/20 0.64
KMT2A Q03164 3/20 0.64
NPSR1 Q6W5P4 3/20 0.64
MEN1 O00255 2/20 0.64
USP2 O75604 1/20 0.64
PTK2 Q05397 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404885 0.91 TSHR (0.72) CYP3A4CYP2C9TNKS2SMN1; SMN2HPGD
SCHEMBL6408279 0.88 CYP3A4 (0.80) CYP3A4CYP2C9TNKS2SMN1; SMN2TP53
SCHEMBL6410759 0.88 CYP3A4 (0.83) CYP3A4CYP2C9TNKS2SMN1; SMN2MAPK1
SCHEMBL6404838 0.85 CYP3A4 (0.78) CYP3A4CYP2C9SMN1; SMN2MAPK1TSHR
SCHEMBL11919908 0.84 NPSR1 (0.90) CYP3A4CYP2C9TNKS2TNKSSMN1; SMN2
SCHEMBL27952226 0.84 MAPK1 (0.71) SMN1; SMN2HPGDGAAMAPK1TSHR
SCHEMBL28375277 0.84 SMN1; SMN2 (0.62) CYP3A4CYP2C9SMN1; SMN2HPGDGAA
SCHEMBL6402486 0.83 CYP3A4 (0.72) CYP3A4CYP2C9TNKS2SMN1; SMN2MAPK1
SCHEMBL16010756 0.82 TNKS2 (1.00) CYP3A4CYP2C9TNKS2TNKSSMN1; SMN2
SCHEMBL6406121 0.81 SMN1; SMN2 (0.65) CYP3A4TNKS2SMN1; SMN2HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP3A4 25/4885CYP2C9 128/4885TNKS2 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.